Diary - News
All news genOway announces capacity expansion at new facilities
Lyon, France, May 30th: genOway (Alternext-NYSE Euronext: ALGEN; ISIN: FR0004053510), the biotechnology company dedicated to the design and development of genetically modified models, is celebrating the purchase of brand new laboratory located in Lyon Biopole-Techsud with operation beginning in early 2018. This significant expansion of capacity showcases the fruit of genOway’s investment in growth that will greatly enhance its service and production capabilities.